<?xml encoding="utf-8" ?> ResMed RMD reported first-quarter financial results on Thursday. The transcript from the company’s ...
Agentic AI is live in healthcare, from prior auth to trial screening. A doctor explains how the Hugging Face hack shows why ...
AD]Your mouse slips during a crucial FPS firefight.You're focused on a boss battle, and your controller is sticky with ...
Shrinking revenue hasn’t kept Teladoc Health (NYSE:TDOC) from beating estimates on both sales and earnings. Early signs that ...
A hacker obtained personally identifiable information about more than 40,000 Homeland Security staffers, which has since been ...
A study of 24 post-therapy SPECT/CT scans found threshold-based segmentation far more reproducible than gradient-based ...
On this episode of Women @ RopesTalk hosted by health care partner Christine Moundas, IP transactions and licensing partner Megan Baca is joined ...
A new review outlines ten concrete measures, from phage selection to dosage modelling, for improving the consistency of phage ...
On the 23rd, the Dow Jones Industrial Average closed at $52,215.16, the S&P 500 at 7,623.68, and the Nasdaq Composite at ...
The influx of novel therapies is expanding treatment options for patients with cancer, but distance, infrastructure, and ...
Alicia Jackson endorsed a key FDA policy change on hormone replacement therapies while holding at least $115,000 in stock in ...
Moderna gave investors a scare as its stock plunged on Thursday. But it's still one of the hottest biotechs this year. And it's hardly alone – the sector is on a roll and looks poised for more gains.